Non-fatal overdose risk during and after opioid agonist treatment: A primary care cohort study with linked hospitalisation and mortality records.

Domzaridou E, Carr MJ, Webb RT, Millar T, Ashcroft DM

Open source

DOI
10.1016/j.lanepe.2022.100489
Published
2022 Nov
Container
The Lancet regional health. Europe
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.lanepe.2022.100489,
  title = {Non-fatal overdose risk during and after opioid agonist treatment: A primary care cohort study with linked hospitalisation and mortality records.},
  author = {Domzaridou E and Carr MJ and Webb RT and Millar T and Ashcroft DM},
  year = {2022},
  journal = {The Lancet regional health. Europe},
  doi = {10.1016/j.lanepe.2022.100489},
  url = {https://doi.org/10.1016/j.lanepe.2022.100489}
}

RIS

TY  - JOUR
TI  - Non-fatal overdose risk during and after opioid agonist treatment: A primary care cohort study with linked hospitalisation and mortality records.
AU  - Domzaridou E
AU  - Carr MJ
AU  - Webb RT
AU  - Millar T
AU  - Ashcroft DM
PY  - 2022
JO  - The Lancet regional health. Europe
DO  - 10.1016/j.lanepe.2022.100489
UR  - https://doi.org/10.1016/j.lanepe.2022.100489
ER  - 

APA

E, D., MJ, C., RT, W., T, M., & DM, A. (2022). Non-fatal overdose risk during and after opioid agonist treatment: A primary care cohort study with linked hospitalisation and mortality records.. The Lancet regional health. Europe. https://doi.org/10.1016/j.lanepe.2022.100489

Source records